Lobe Sciences Ltd. (CVE:LOBE) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 06/09/2026 at 12:05, 11 days 15 hours ago

Lobe Sciences accroît sa participation dans la direction par le biais d'un règlement en actions

Recherche Et Développement Programmes Cliniques Sciences Du Lobe Modèle De Filiale Règlement En Actions
BRIEF

published on 06/09/2026 at 12:05, 11 days 15 hours ago

Lobe Sciences Increases Management Equity Through Share Settlement

Research And Development Clinical Programs Lobe Sciences Subsidiary Model Equity Settlement
PRESS RELEASE

published on 06/09/2026 at 12:00, 11 days 15 hours ago

Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares
Lobe Sciences Ltd. settles accrued management fees through issuance of common shares, strengthening ownership alignment with shareholders and maintaining strong financial position with C$4.96 million in cash and short-term investments

Financial Position Share Issuance Clinical-Stage Biopharmaceutical Lobe Sciences Ltd. Subsidiary R&D Programs
BRIEF

published on 06/02/2026 at 04:05, 18 days 23 hours ago

Lobe Sciences to Resolve Debt Through Share Issuance

Debt Settlement Biopharmaceutical Regulatory Approval Share Issuance Therapeutic Development
BRIEF

published on 06/02/2026 at 04:05, 18 days 23 hours ago

Lobe Sciences va résoudre sa dette par une émission d'actions

Biopharmaceutique Émission D'actions Règlement De Dettes Approbation Réglementaire Développement Thérapeutique
PRESS RELEASE

published on 06/02/2026 at 04:00, 18 days 23 hours ago

Lobe Sciences Announces Proposed Shares for Debt Transaction
Lobe Sciences announces agreement to settle outstanding management and director fee debt through issuance of common shares. Debt Settlement subject to regulatory approvals

Management Regulatory Approvals Settlement Shares Lobe Sciences Director Fee Debt
BRIEF

published on 05/07/2026 at 02:05, 1 month 14 days ago

Lobe Sciences Ltd. to Attend D. Boral Capital Global Conference

Drug Development Biopharmaceutical Global Conference Sickle Cell Disease Psilocin
BRIEF

published on 05/07/2026 at 02:05, 1 month 14 days ago

Lobe Sciences Ltd. participera à la conférence mondiale de D. Boral Capital.

Biopharmaceutique Développement De Médicaments Conférence Mondiale Drépanocytose Psilocine
PRESS RELEASE

published on 05/07/2026 at 02:00, 1 month 14 days ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Lobe Sciences Ltd. announces CEO participation in D. Boral Capital Global Conference to discuss therapeutic programs and drug candidates

Clinical-Stage Biopharmaceutical Drug Candidates Lobe Sciences Ltd. Therapeutic Programs D. Boral Capital Global Conference
BRIEF

published on 05/06/2026 at 12:05, 1 month 14 days ago

Lobe Sciences publie ses résultats financiers et son bilan opérationnel du deuxième trimestre 2026

Résultats Financiers Placement Privé Perte Nette Investissement En R&D Développement De Médicaments

1 2 ... 9

Accesswire

Published on 06/20/2026 at 01:00, 1 day 2 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 3 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 22 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 1 hour ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 2 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 5 hours 47 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 21 hours 12 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 6 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 6 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 7 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 7 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 7 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 7 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 8 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE